0001596274-14-000001.txt : 20140820 0001596274-14-000001.hdr.sgml : 20140820 20140820142245 ACCESSION NUMBER: 0001596274-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140820 DATE AS OF CHANGE: 20140820 EFFECTIVENESS DATE: 20140820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immusoft Corp CENTRAL INDEX KEY: 0001596274 IRS NUMBER: 271394946 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-223329 FILM NUMBER: 141054581 BUSINESS ADDRESS: STREET 1: 2800 ELLIOTT AVENUE STREET 2: SUITE 414 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-931-0262 MAIL ADDRESS: STREET 1: 2800 ELLIOTT AVENUE STREET 2: SUITE 414 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0707 D LIVE 0001596274 Immusoft Corp 2800 ELLIOTT AVENUE SUITE 414 SEATTLE WA WASHINGTON 98121 206-931-0262 WASHINGTON None None Corporation true Matthew Scholz c/o Immusoft Corporation 2800 Elliott Avenue, Suite #414 Seattle WA WASHINGTON 98121 Executive Officer Director Mark Ahn, Ph.D. c/o Galena Biopharma, Inc. 4640 SW Macadam Ave., Suite 270 Portland OR OREGON 97239 Director Richard Chin, M.D. c/o Immusoft Corporation 2800 Elliott Avenue, Suite #414 Seattle WA WASHINGTON 98121 Director Eric Garcia c/o Immusoft Corporation 2800 Elliott Avenue, Suite #414 Seattle WA WASHINGTON 98121 Executive Officer Biotechnology Decline to Disclose 06b false 2014-08-06 false true false 0 3286771 2374458 912313 false 11 0 0 0 false Immusoft Corp /s/ Matthew Scholz Matthew Scholz Chief Executive Officer 2014-08-20